These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28894355)

  • 1. Erratum: Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum].
    Clin Ophthalmol; 2017; 11():1567. PubMed ID: 28894355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study.
    Korol AR; Zborovska O; Kustryn T; Dorokhova O; Pasyechnikova N
    Clin Ophthalmol; 2017; 11():1315-1320. PubMed ID: 28769551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum: A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum].
    Clin Ophthalmol; 2017; 11():303. PubMed ID: 28223773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum.
    Paediatr Child Health; 2015; 20(8):466-7. PubMed ID: 26744561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal aflibercept for the treatment of choroidal neovascularization associated with pathologic myopia: a pilot study.
    Korol AR; Zadorozhnyy OS; Naumenko VO; Kustryn TB; Pasyechnikova NV
    Clin Ophthalmol; 2016; 10():2223-2229. PubMed ID: 27853350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization.
    Wang JK; Huang TL; Chang PY; Chen YT; Chang CW; Chen FT; Hsu YR; Chen YJ
    Sci Rep; 2018 Sep; 8(1):14389. PubMed ID: 30258077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum].
    Clin Ophthalmol; 2017; 11():355. PubMed ID: 28243059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aflibercept efficacy in refractory choroidal neovascularization.
    Brănişteanu DC; Bîlhă A; Moraru A
    Rom J Ophthalmol; 2016; 60(2):96-102. PubMed ID: 29450330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum].
    Clin Ophthalmol; 2017; 11():619. PubMed ID: 28435211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis.
    Makragiannis G; Vahdani K; Carreño E; Lee RWJ; Dick AD; Ross AH
    Int Ophthalmol; 2018 Apr; 38(2):781-785. PubMed ID: 28361379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab.
    Saitta A; Nicolai M; Neri P; Reibaldi M; Giovannini A; Mariotti C
    Int Ophthalmol; 2015 Jun; 35(3):441-4. PubMed ID: 25761547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Ex vivo distribution of gold nanoparticles in choroidal melanoma [Corrigendum].
    Int J Nanomedicine; 2018; 13():1295. PubMed ID: 29569644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization: The MYRROR Study.
    Ikuno Y; Ohno-Matsui K; Wong TY; Korobelnik JF; Vitti R; Li T; Stemper B; Asmus F; Zeitz O; Ishibashi T;
    Ophthalmology; 2015 Jun; 122(6):1220-7. PubMed ID: 25745875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration [Corrigendum].
    Clin Interv Aging; 2016; 11():775. PubMed ID: 27358559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choroidal neovascularization associated with West Nile virus chorioretinitis.
    Seth RK; Stoessel KM; Adelman RA
    Semin Ophthalmol; 2007; 22(2):81-4. PubMed ID: 17564926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection.
    Saito M; Kano M; Itagaki K; Ise S; Imaizumi K; Sekiryu T
    Jpn J Ophthalmol; 2016 Jan; 60(1):35-41. PubMed ID: 26350229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization.
    Sayanagi K; Uematsu S; Hara C; Wakabayashi T; Fukushima Y; Sato S; Ikuno Y; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):749-757. PubMed ID: 30643966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal aflibercept for myopic choroidal neovascularization.
    Pece A; Milani P
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2327-2332. PubMed ID: 27286893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal aflibercept for the treatment of choroidal neovascularization associated with rubella retinopathy.
    Kiziltoprak H; Yetkin E; Tekin K; Koc M; Akalin İ; Teke MY
    Int Ophthalmol; 2019 Feb; 39(2):477-484. PubMed ID: 29411259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.